Korro Bio, Inc. (KRRO)
NASDAQ·Healthcare·Biotechnology
$10.13
-3.52%
Mkt Cap $115.83M
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$19.57
Range $10.00 – $30.00
Implied Upside
+93.2%
Consensus $19.57 vs current $10.13
NASDAQ·Healthcare·Biotechnology
$10.13
-3.52%
Mkt Cap $115.83M
No recent rating data.
Price Target (15 analysts)
$19.57
Range $10.00 – $30.00
+93.2%
Consensus $19.57 vs current $10.13